Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3
World
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3
World
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Official URL: https://fevir.net/resources/EvidenceVariable/179784 | Version: 1.0.0-ballot3 | ||||
| Standards status: Informative | Computable Name: Therapeutic_dose_anticoagulation_with_heparin_vs_Usual_care_pharmacologic_thromboprophylaxis | ||||
| Other Identifiers: FEvIR Object Identifier: FEvIR Object Identifier#179784, OID:2.16.840.1.113883.4.642.40.44.24.149 | |||||
Usage: Evidence Communication: group-assignment |
|||||
Copyright/Legal: https://creativecommons.org/licenses/by-nc-sa/4.0/ |
|||||
Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis in multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19
version: 3; Last updated: 2023-12-01 22:26:01+0000
Profile: GroupAssignment
ArtifactPublicationStatus: Active
identifier: FEvIR Object Identifier/179784, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.24.149
version: 1.0.0-ballot3
name: Therapeutic_dose_anticoagulation_with_heparin_vs_Usual_care_pharmacologic_thromboprophylaxis
title: GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis
citeAs:
GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179784. Revised 2023-11-30. Available at: https://fevir.net/resources/EvidenceVariable/179784. Computable resource at: https://fevir.net/resources/EvidenceVariable/179784.
status: Active
date: 2026-11-05 14:34:28+0000
author: Brian S. Alper:
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
description:
Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis in multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19
| Code | Value[x] |
| Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication (Evidence Communication) | group-assignment |
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
| Concept |
| Defined in handling and category elements |
handling: dichotomous variable
category
name: Therapeutic-dose anticoagulation with heparin
value: ExposureDefinition: Therapeutic-dose anticoagulation with heparin
category
name: Usual-care pharmacologic thromboprophylaxis
value: ComparatorDefinition: Usual-care pharmacologic thromboprophylaxis
IG © 2024+ HL7 International / Clinical Decision Support.
Package hl7.fhir.uv.ebm#1.0.0-ballot3 based on FHIR 6.0.0-snapshot1.
Generated
2026-11-05
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change